BamSEC and AlphaSense Join Forces
Learn More

Sangamo Therapeutics Inc.

NASDAQ: SGMO    
Share price (12/20/24): $2.47    
Market cap (12/20/24): $515 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.2
from S-3 3 pages Amendment No. 4 to Open Market Sale Agreementsm November 12, 2024
12/34/56
EX-1.1
from 8-K 3 pages Amendment No. 3 to Open Market Sale Agreementsm March 7, 2023
12/34/56
EX-1.1
from 8-K 3 pages Amendment No. 2 to Open Market Sale Agreement December 23, 2022
12/34/56
EX-1.3
from S-3ASR 3 pages Amendment No. 1 to Open Market Sale Agreement May 5, 2021
12/34/56
EX-1.1
from 10-Q 43 pages Open Market Sale Agreement1
12/34/56
EX-1.1
from 8-K 38 pages Sangamo Therapeutics, Inc. 11,000,000 Shares of Common Stock Par Value $0.01 Per Share Underwriting Agreement
12/34/56
EX-1.1
from 8-K 37 pages Sangamo Therapeutics, Inc. 12,310,000 Shares of Common Stock Par Value $0.01 Per Share Underwriting Agreement
12/34/56
EX-1.1
from 8-K 40 pages 10,000,000 Shares Sangamo Therapeutics, Inc. Common Stock, $0.01 Par Value Underwriting Agreement
12/34/56
EX-1.1
from 8-K 40 pages Sangamo Therapeutics, Inc. Amended and Restated At-The-Market Offering Program Sales Agreement
12/34/56
EX-1.1
from 8-K 34 pages Sangamo Biosciences, Inc. At-The-Market Offering Program Sales Agreement
12/34/56
EX-1.1
from 8-K 34 pages Sangamo Biosciences, Inc. 4,444,444 Shares of Common Stock Par Value $0.01 Underwriting Agreement
12/34/56
EX-1.1
from 8-K 41 pages 6,100,000 Shares of Common Stock Par Value $0.001 915,000 Over-Allotment Shares Sangamo Biosciences, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 32 pages 6,700,000 Shares Sangamo Biosciences, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 36 pages 3,000,000 Shares Sangamo Biosciences, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 39 pages 3,278,689 Shares Sangamo Biosciences, Inc. Common Stock Placement Agency Agreement
12/34/56
EX-1.1
from 8-K 31 pages 3,100,000 Shares Sangamo Biosciences, Inc. Common Stock Purchase Agreement
12/34/56
EX-1.1
from 8-K 27 pages 5,080,000 Shares Sangamo Biosciences, Inc. Common Stock Placement Agency Agreement
12/34/56
EX-1.1
from S-1/A ~50 pages Underwriting Agreement
12/34/56